Adaptyv Biosystems
Adaptyv Biosystems, based in Lausanne, Switzerland, specializes in high-throughput protein synthesis and screening, aiming to revolutionize drug discovery and delivery by building the world's largest protein design database.
Company Overview
Adaptyv Biosystems, based in Lausanne, VD, Switzerland, operates in the healthcare industry, focusing on drug discovery and delivery. The company is known for its innovative approach to protein synthesis and screening, utilizing nanofluidic chip technology to make these processes significantly more affordable.
Innovative Protein Synthesis Technology
Adaptyv Biosystems has developed a miniaturized protein synthesis and screening platform, leveraging nanofluidic chip technology. This innovation reduces costs by 100,000 times compared to existing technologies. Their next-generation protein foundry can synthesize and test any protein design efficiently and economically, which is a groundbreaking development in the field.
Y Combinator S21 Batch
Adaptyv Biosystems was part of the Y Combinator S21 batch. This association has provided significant support, bolstering the company's growth and innovation capabilities. Y Combinator's backing has been instrumental in driving Adaptyv's ambitious projects and technological advances.
Services Offered
Adaptyv Biosystems offers high-throughput protein synthesis and screening services. Their 'Foundry Early Access' program provides early access to their state-of-the-art protein engineering foundry. Pricing for their protein engineering services starts at 99 USD per protein, with discounts and preferential access available for customers committing to monthly packages.
Strategic Support and Partnerships
Adaptyv Biosystems is supported by prominent institutions and organizations, including Y Combinator, EPFL, and Wingman. These partnerships have played a crucial role in advancing Adaptyv's mission to build the world's largest protein design database and to develop new therapeutics for previously untreatable diseases.
